Mapping Interactions with the Chaperone Network Reveals Factors that Protect Against Tau Aggregation

Autor: Bryan M. Dunyak, Jungsoon Lee, Mark R. Wilson, Harindranath Kadavath, Victoria A. Assimon, Francis T.F. Tsai, Olivier Julien, Chad A. Dickey, Jennifer N. Rauch, Markus Zweckstetter, Rebecca Freilich, Sue-Ann Mok, Anne T. Gillies, Jason E. Gestwicki, Carlo Condello, Javier Oroz, Taylor Arhar
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Aging
Regulator
protein-protein interactions
Neurodegenerative
Alzheimer's Disease
Medical and Health Sciences
Biochemistry
purified proteins
metabolism [HSP40 Heat-Shock Proteins]
0302 clinical medicine
Structural Biology
protein folding
2.1 Biological and endogenous factors
Aetiology
biology
Brain
Biological Sciences
Protein folding
physiology [Protein Binding]
Protein Binding
Tau pathology
Tau protein
Biophysics
MAPT protein
human

tau Proteins
Computational biology
DNAJA2 protein
human

Protein Aggregation
Pathological

prevention & control [Protein Aggregation
Pathological]

Article
protein aggregation
03 medical and health sciences
Protein Aggregates
Pathological
ddc:570
mental disorders
Acquired Cognitive Impairment
Humans
physiology [Protein Aggregates]
protein quality control
Molecular Biology
tauopathy
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
HSP40 Heat-Shock Proteins
Protein Aggregation
metabolism [tau Proteins]
Brain Disorders
030104 developmental biology
metabolism [Brain]
Chaperone (protein)
Chemical Sciences
heat shock proteins
biology.protein
Proteostasis
Dementia
030217 neurology & neurosurgery
Developmental Biology
Neuroscience
Zdroj: Nature structural & molecular biology
Nature Structural and Molecular Biology
Nature structural & molecular biology 25(5), 384-393 (2018). doi:10.1038/s41594-018-0057-1
Nature structural & molecular biology, vol 25, iss 5
ISSN: 1545-9985
1545-9993
Popis: A network of molecular chaperones is known to bind proteins (“clients”) and balance their folding, function and turnover. However, it is often not clear which chaperones are critical for selective recognition of individual clients. It is also not clear why these key chaperones might fail in protein aggregation diseases. In this study, we utilized human microtubule-associated protein tau (MAPT or tau) as a model client to survey interactions between ~30 purified chaperones and ~20 disease-associated tau variants (~600 combinations). From this large-scale analysis, we identified human DnaJA2 as an unexpected, but potent, inhibitor of tau aggregation. DnaJA2 levels were correlated with tau pathology in human brains, supporting the idea that it is an important regulator of tau homeostasis. Of significance, we found that some disease-associated tau variants were relatively immune to interactions with chaperones, suggesting a model in which avoiding physical recognition by chaperone networks may contribute to disease. Impact Statement Large-scale screening of chaperone interactions with tau and its variants identified DnaJA2 as a key protective factor in tauopathy.
Databáze: OpenAIRE